TOP STORIES

• BUSINESS Datroway, Zeposia, and More Meds Now Available in Japan; Zepbound Launch Set for April 11
  March 21, 2025

• REGULATORY US Chamber Raises Japan’s Pharma Policy as Unfair Trade Practice, Prods Federal Govt for Action
  March 19, 2025

• BUSINESS Novartis CEO Touts Plan to Amp Up Japan Investment, Add 50 Jobs for Early Trials
  March 18, 2025

• BUSINESS Jiho Survey Finds Improvement in Price Revision Rates for Generic Players
  March 17, 2025

• BUSINESS KalVista Eyes Japan Debut with World’s 1st Oral On-Demand HAE Drug
  March 14, 2025

• REGULATORY MHLW Panel OKs List of “High-Priority” Vaccines, including Norovirus Jabs
  March 14, 2025

• REGULATORY Zepbound, Qalsody, and More New Drugs Set for Japan Listing on March 19
  March 13, 2025

• BUSINESS More than Half of Drug Makers’ Top 5 Meds See Flat or Positive Revisions: Poll
  March 12, 2025

• BUSINESS Two-Thirds of Drug Makers Discontent with FY2025 Price Revision: Survey
  March 11, 2025

• BUSINESS Drug Makers Weigh Withdrawal of Unprofitable Drugs, Generic and Innovative Players Alike: Poll
  March 11, 2025

• BUSINESS Japan Drug Makers See Varied Impact from 2025 Revision, Foreign Firms Take Hit: Poll
  March 10, 2025

• REGULATORY Stelara to Get 40.8% Price Cut on PMP Return, Januvia Over 26% in 2025 Revision
  March 10, 2025

• REGULATORY MHLW Unveils New List Prices for FY2025 Revision; Stelara, Januvia Hit by PMP Return
  March 7, 2025

• REGULATORY Takeda’s Livmarli, BMS’s Camzyos, and More Inch Closer to Japan Approval
  March 7, 2025

• ORGANIZATION Cough Drug Asverin Tops Supply Shortage Ranking in Japan: P-Cubed Survey
  March 6, 2025

• BUSINESS Unexpected Demand Triggers Supply Curb for Eisai’s ALS Med Just 3 Months after Launch; Patients Urge Early Response
  March 5, 2025

• BUSINESS Sumitomo Group Continues to Seek Best Partners for Pharma Biz
  March 5, 2025

• BUSINESS Japan Pharma Market Hits 11.5 Trillion Yen in 2024, Keytruda Wins Crown: IQVIA
  March 5, 2025

• COMMENTARY Evolving GLP-1 Drugs: Could Double and Triple Agonists Achieve Blockbuster Status?
  March 4, 2025

• BUSINESS 680 Employees Exit Takeda in Buyout Program, 10%-Plus of Japan Staff
  March 4, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• …
• Next ›
• 最終 »